ArticleMolecular cancer2015

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.

Marijn T M van Jaarsveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.